The second quarter Venture Monitor report from Pitchbook and the National Venture Capital Association noted a record level of venture capital exits totaling $165.2bn for the first half of 2019, including 42 biopharmaceutical initial public offerings plus mergers and acquisitions totaling $13.9bn.
The Pitchbook-NVCA Venture Monitor noted that the exits were driven largely by initial public offerings – particularly biopharma offerings –...






